drugset / Trial / NCT06655870
A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to test the safety of mRNA-0184 in healthy participants.
Timeline
- Start
- 2024-10-31
- Primary completion
- 2026-06-23
- Completion
- 2026-06-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mRNA-0184 | Unknown | — | Subcutaneous |
Indications
No indication recorded.